APC and colorectal cancer: Furthermore, in colorectal cancer cells that have overactive β-catenin, TCF-4 is known to be growth inhibitory, as RNAi-mediated disruption of its expression facilitates β-catenin activity and cell growth in both DLD-1 cells (APC mutation) and HCT116 cells (activating β-catenin mutation) [57].